Elizabeth A Coker
5PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu
|Apr 03, 2022
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes.Elizabeth A Coker, Adam Stewart, Bugra Ozer
|Dec 04, 2020
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib.Vikki Flemington, Emma J Davies, David Robinson
|Sep 29, 2020
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Srividya B Balachander, Steven W Criscione, Kate F Byth
|Jul 03, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant Cancers.Adam Stewart, Elizabeth A Coker, Sebastian Pölsterl
Pageof 1
Frequent Collaborators
3 joint publications
Mathew J Garnett
3 joint publications
Patricia Jaaks
2 joint publications
Mary O'Brien
2 joint publications
Bissan Al-Lazikani
2 joint publications
Udai Banerji
2 joint publications
Justin Cidado
2 joint publications
Francis D Gibbons
2 joint publications
Omid Tavana
1 joint publications
Kate F Byth
1 joint publications
Shenghua Wen
